Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 118 (2) , 328-336
- https://doi.org/10.1016/0008-8749(89)90381-x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- 1,25 Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase.Journal of Clinical Investigation, 1986
- Reconstitution of Natural-Killer-Cell Activity in the Newborn by Interleukin-2New England Journal of Medicine, 1986
- Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.The Journal of Experimental Medicine, 1985
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984
- Calcium Transport Proteins, Calcium Absorption, and Vitamin DAnnual Review of Physiology, 1983
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983
- Biochemical properties of 1α,25-dihydroxyvitamin D receptorsJournal of Steroid Biochemistry, 1980
- “NK-like” cytotoxicity of human lymphocytes cultured in media containing fetal bovine serumInternational Journal of Cancer, 1979